These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Delayed-type hypersensitivity to heparin with tolerance of its intravenous administration. Irion R; Gall H; Peter RU Contact Dermatitis; 2000 Oct; 43(4):249-50. PubMed ID: 11011948 [No Abstract] [Full Text] [Related]
5. Acral hemorrhagic blisters induced by reviparin. Pathania YS; Md AB Int J Dermatol; 2019 Nov; 58(11):1329-1330. PubMed ID: 30843199 [No Abstract] [Full Text] [Related]
6. Delayed-type hypersensitivity to heparins: different patterns of cross-reactivity. Palacios Colom L; Alcántara Villar M; Luis Anguita Carazo J; Ruiz Villaverde R; Quiralte Enríquez J Contact Dermatitis; 2008 Dec; 59(6):375-7. PubMed ID: 19076893 [No Abstract] [Full Text] [Related]
8. [Long-term low-molecular-weight heparin therapy during pregnancy: is there a bone risk?]. Khalifa P; Marie-Scemama L Therapie; 2013; 68(1):37-42. PubMed ID: 23484659 [TBL] [Abstract][Full Text] [Related]
9. Extended venous thromboembolism prophylaxis after total hip replacement: a comparison of low-molecular-weight heparin with oral anticoagulant. Samama CM; Vray M; Barré J; Fiessinger JN; Rosencher N; Lecompte T; Potron G; Basile J; Hull R; Desmichels D; Arch Intern Med; 2002 Oct; 162(19):2191-6. PubMed ID: 12390061 [TBL] [Abstract][Full Text] [Related]
11. [Efficient ambulatory and post-discharge thromboprophylaxis with fully automated pens]. Höntzsch D; Scheffer J; Hafner S Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():1060-2. PubMed ID: 9574332 [TBL] [Abstract][Full Text] [Related]
12. Low-molecular-weight heparin and thromboembolism in pregnancy. Tam WH; Wong KS; Yuen PM; Leung TN; Li CY Lancet; 1999 Mar; 353(9156):932. PubMed ID: 10094020 [No Abstract] [Full Text] [Related]
13. Skin necrosis at the injection site induced by low-molecular-weight heparin: case report and review. Santamaría A; Romaní J; Souto JC; López A; Mateo J; Fontcuberta J Dermatology; 1998; 196(2):264-5. PubMed ID: 9568422 [TBL] [Abstract][Full Text] [Related]
14. Occurrence and extent of bruising according to duration of administration of subcutaneous low-molecular-weight heparin: a quasi-experimental case-crossover study. Palese A; Aidone E; Dante A; Pea F J Cardiovasc Nurs; 2013; 28(5):473-82. PubMed ID: 22760174 [TBL] [Abstract][Full Text] [Related]
15. Subcutaneous low molecular weight heparin in unstable angina. Thomas G Indian Heart J; 1997; 49(5):556-7. PubMed ID: 9505033 [No Abstract] [Full Text] [Related]
16. Unsuspected Colonic Hemorrhage Found on Screening Colonoscopy. Jangouk P; Chang JJ; Imaeda AB Gastroenterology; 2017 May; 152(6):e10-e11. PubMed ID: 28384453 [No Abstract] [Full Text] [Related]
17. [Low-molecular weight heparin in the treatment of pregnant women with high thrombotic risk]. Todorova K; Mazneĭkova V; Ivanov S Akush Ginekol (Sofiia); 2004; 43(4):46-52. PubMed ID: 15318544 [No Abstract] [Full Text] [Related]
18. [Massive abdominal wall hematoma and hemperitoneum secondary to subcutaneous infusion of low molecular weight heparin]. García-Jiménez A; Alcázar Montero JA; Fernández González CJ; Buño Ramiro B; Lamas García FD; García de Castro R; Merino Rego MD Rev Esp Anestesiol Reanim; 2005 Nov; 52(9):572-3. PubMed ID: 16363305 [No Abstract] [Full Text] [Related]
19. [Initial results of the PROTECT Study publicized. Stroke patients need effective thrombosis prevention]. Diener HC MMW Fortschr Med; 2005 Jun; 147(22):50. PubMed ID: 15977636 [No Abstract] [Full Text] [Related]
20. [Use of low molecular weight heparins by dermatologists]. Maakaroun A; Gruel Y Ann Dermatol Venereol; 2003 Apr; 130(4):473-8. PubMed ID: 12843865 [No Abstract] [Full Text] [Related] [Next] [New Search]